Patent · US Active

Methods for treatment of ocular diseases

US8877183B2 · kind B2 · utility

0Cited by

3References

24Claims

0Family size

Assignees

NATIONAL INSTITUTES OF HEALTH (NIH) · US
U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS) · US
NIH Division of Extramural Inventions and Technology Resources (DEITR) · US

Inventors

Timothy Paul Foster · Slidell, US
Paulo Cesar Rodriguez · Slaughter, US
James M. Hill · Lake Jackson, US
Augusto C. Ochoa · Windom, US

Key dates

Filing date	Mar 14, 2013
Grant date	Nov 4, 2014
Priority date	—
Expiry date	Mar 14, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y305/03001
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and therapeutic treatments of ocular diseases are provided including applying peg-Arginase I to affected eyes. Methods are provided that simultaneously treat inflammation and neovascularization of eyes while promoting healing. Methods are provided to treat lesions or infections of an eye.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.